These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
586 related articles for article (PubMed ID: 28938728)
1. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy. Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728 [TBL] [Abstract][Full Text] [Related]
2. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330 [TBL] [Abstract][Full Text] [Related]
3. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation. Fraison E; Huberlant S; Labrune E; Cavalieri M; Montagut M; Brugnon F; Courbiere B Hum Reprod; 2023 Mar; 38(3):489-502. PubMed ID: 36421038 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of ovarian function preservation with GnRH agonist during chemotherapy in premenopausal women with early breast cancer. Huang Y; Huang X; Huang X; Lin S; Luo S; Gu D; Weng X; Xu X Hum Reprod; 2023 Jun; 38(6):1099-1110. PubMed ID: 37075316 [TBL] [Abstract][Full Text] [Related]
6. Assisted reproductive technology use and outcomes among women with a history of cancer. Luke B; Brown MB; Missmer SA; Spector LG; Leach RE; Williams M; Koch L; Smith YR; Stern JE; Ball GD; Schymura MJ Hum Reprod; 2016 Jan; 31(1):183-9. PubMed ID: 26577302 [TBL] [Abstract][Full Text] [Related]
7. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection. Johnston M; Richings NM; Leung A; Sakkas D; Catt S Hum Reprod; 2021 Feb; 36(3):624-635. PubMed ID: 33367704 [TBL] [Abstract][Full Text] [Related]
8. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response. Alvarez RM; Ramanathan P Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358 [TBL] [Abstract][Full Text] [Related]
9. Fertility preservation for social indications: a cost-based decision analysis. Hirshfeld-Cytron J; Grobman WA; Milad MP Fertil Steril; 2012 Mar; 97(3):665-70. PubMed ID: 22265038 [TBL] [Abstract][Full Text] [Related]
11. Optimal timing for elective egg freezing. Mesen TB; Mersereau JE; Kane JB; Steiner AZ Fertil Steril; 2015 Jun; 103(6):1551-6.e1-4. PubMed ID: 25881876 [TBL] [Abstract][Full Text] [Related]
12. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy. Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188 [TBL] [Abstract][Full Text] [Related]
13. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation. Walker Z; Lanes A; Ginsburg E Reprod Biol Endocrinol; 2022 Jan; 20(1):10. PubMed ID: 34996479 [TBL] [Abstract][Full Text] [Related]
14. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307 [TBL] [Abstract][Full Text] [Related]
15. Exploring the knowledge, attitudes, and perceptions of women of reproductive age towards fertility and elective oocyte cryopreservation for age-related fertility decline in the UK: a cross-sectional survey. Kasaven LS; Mitra A; Ostrysz P; Theodorou E; Murugesu S; Yazbek J; Bracewell-Milnes T; Ben Nagi J; Jones BP; Saso S Hum Reprod; 2023 Dec; 38(12):2478-2488. PubMed ID: 37816663 [TBL] [Abstract][Full Text] [Related]
16. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139 [TBL] [Abstract][Full Text] [Related]
17. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Martinez F Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320 [TBL] [Abstract][Full Text] [Related]
18. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065 [TBL] [Abstract][Full Text] [Related]
19. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study. Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035 [TBL] [Abstract][Full Text] [Related]
20. Enhancing the scope of in vitro maturation for fertility preservation: transvaginal retrieval of immature oocytes during endoscopic gynaecological procedures. Song XL; Lu CL; Zheng XY; Nisenblat V; Zhen XM; Yang R; Li M; Li R; Yuan YF; Ma CH; Liu P; Feng HL; Yan J; Qiao J Hum Reprod; 2020 Apr; 35(4):837-846. PubMed ID: 32154563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]